Evidence map›Paper›PMID 38229579›Full record

Trial reportHealth technology assessment (Winchester, England)2024

A tailored psychological intervention for anxiety and depression management in people with chronic obstructive pulmonary disease: TANDEM RCT and process evaluation.

Ratna Sohanpal, Hilary Pinnock, Liz Steed, Karen Heslop-Marshall, Moira J Kelly, Claire Chan, Vari Wileman, Amy Barradell, Clarisse Dibao-Dina, Paulino Font Gilabert and 13 more

Open access · diamondAbstract readRandomized Controlled TrialMulticenter StudyPragmatic Clinical Trial
In one paragraph

Trial report in Health technology assessment (Winchester, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 2 countries.

Ratna SohanpalWolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0002-1732-0305
Hilary PinnockAllergy and Respiratory Research Group, Usher Institute, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-5976-8386
Liz SteedWolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0003-1926-3196
Karen Heslop-MarshallNewcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.ORCID 0000-0002-5990-6961
Moira J KellyWolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0001-7911-1149
Claire ChanWolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0002-0821-4068
Vari WilemanSchool of Mental Health and Psychological Sciences, Institute of Psychiatry, King's College London, London, UK.ORCID 0000-0002-9673-8047
Amy BarradellUniversity Hospitals of Leicester NHS Trust, Leicester, UK.ORCID 0000-0002-3688-8879
Clarisse Dibao-DinaFaculté de médecine de Tours, Université de Tours, Tours, France.ORCID 0000-0002-1750-2846
Paulino Font GilabertHealth Service and Population Research Department, Institute of Psychiatry, King's College London, London, UK.ORCID 0000-0002-6280-5483
Andy HealeyHealth Service and Population Research Department, Institute of Psychiatry, King's College London, London, UK.ORCID 0000-0003-2013-3161
Richard HooperWolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0002-1063-0917
Kristie-Marie MammolitiInstitute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.ORCID 0000-0003-3614-7453
Stefan PriebeWolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0001-9864-3394
Mike RobertsSafer Care Victoria, Melbourne, Melbourne, VIC, Australia.ORCID 0000-0001-8212-1460
Vickie RowlandUniversity of the West of England, Bristol, UK.ORCID 0000-0003-2838-1485
Sarah Waseem
Sally SinghUniversity Hospitals of Leicester NHS Trust, Leicester, UK.ORCID 0000-0002-9834-0366
Melanie SmukDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-1594-1458
Martin UnderwoodWarwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0002-0309-1708
Patrick WhiteDepartment of Population Health, School of Population Health and Environmental Sciences, King's College London, London, UK.ORCID 0000-0002-2047-8787
Nahel YazijiHealth Service and Population Research Department, Institute of Psychiatry, King's College London, London, UK.ORCID 0000-0002-2273-7957
Stephanie Jc TaylorWolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0001-7454-6354
Queen Mary University of London · GBKing's College London · GBUniversity Hospitals of Leicester NHS Trust · GBLondon School of Hygiene & Tropical Medicine · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBUniversité de Tours · FRUniversity of Birmingham · GBUniversity of Edinburgh · GBUniversity of the West of England · GBUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: People with chronic obstructive pulmonary disease have high levels of anxiety and depression, which is associated with increased morbidity and poor uptake of effective treatments, such as pulmonary rehabilitation. Cognitive-behavioural therapy improves mental health of people with long-term conditions and could potentially increase uptake of pulmonary rehabilitation, enabling synergies that could enhance the mental health of people with chronic obstructive pulmonary disease. Aim: Our aim was to develop and evaluate the clinical effectiveness and cost effectiveness of a tailored cognitive-behavioural approach intervention, which links into, and optimises the benefits of, routine pulmonary rehabilitation. Design: We carried out a pragmatic multicentre randomised controlled trial using a 1.25 : 1 ratio (intervention : control) with a parallel process evaluation, including assessment of fidelity. Setting: Twelve NHS trusts and five Clinical Commissioning Groups in England were recruited into the study. The intervention was delivered in participant's own home or at a local NHS facility, and by telephone. Participants: Between July 2017 and March 2020 we recruited adults with moderate/very severe chronic obstructive pulmonary disease and mild/moderate anxiety and/or depression, meeting eligibility criteria for assessment for pulmonary rehabilitation. Carers of participants were invited to participate. Intervention: The cognitive-behavioural approach intervention (i.e. six to eight 40- to 60-minute sessions plus telephone support throughout pulmonary rehabilitation) was delivered by 31 trained respiratory healthcare professionals to participants prior to commencing pulmonary rehabilitation. Usual care included routine pulmonary rehabilitation referral. Main outcome measures: Co-primary outcomes were Hospital Anxiety and Depression Scale - anxiety and Hospital Anxiety and Depression Scale - depression at 6 months post randomisation. Secondary outcomes at 6 and 12 months included health-related quality of life, smoking status, uptake of pulmonary rehabilitation and healthcare use. Results: We analysed results from 423 randomised participants (intervention, Conclusions: The tailored cognitive-behavioural approach intervention delivered with fidelity by trained respiratory healthcare professionals to people with chronic obstructive pulmonary disease was neither clinically effective nor cost-effective. Alternative approaches that are integrated with routine long-term condition care are needed to address the unmet, complex clinical and psychosocial needs of this group of patients. Trial registration: This trial is registered as ISRCTN59537391. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 13/146/02) and is published in full in

Indexed as

DepressionPulmonary Disease, Chronic ObstructiveAdultAnxietyCost-Benefit AnalysisHumansPsychosocial InterventionQuality of LifeANXIETYCHRONIC OBSTRUCTIVECOGNITIVE BEHAVIOURAL THERAPYDEPRESSIONECONOMIC EVALUATIONPULMONARY DISEASEQUALITATIVE RESEARCHRANDOMISED CONTROLLED TRIAL

Identifiers

PMID38229579
PMCPMC11017633
OpenAlexW4390955319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.